Chimeric Antigen Receptor (CAR) T Cell Therapy for Metastatic Melanoma: Challenges and Road Ahead

Metastatic melanoma is the most aggressive and difficult to treat type of skin cancer, with a survival rate of less than 10%. Metastatic melanoma has conventionally been considered very difficult to treat; however, recent progress in understanding the cellular and molecular mechanisms involved in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Soltantoyeh, Tahereh, Akbari, Behnia, Karimi, Amirali, Mahmoodi Chalbatani, Ghanbar, Ghahri-Saremi, Navid, Hadjati, Jamshid, Hamblin, Michael R., Mirzaei, Hamid Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230324/
https://www.ncbi.nlm.nih.gov/pubmed/34207884
http://dx.doi.org/10.3390/cells10061450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230324/
https://www.ncbi.nlm.nih.gov/pubmed/34207884
http://dx.doi.org/10.3390/cells10061450

Ejemplares similares